Universal Health (UHS) Tops Q2 EPS by 22c

Go back to Universal Health (UHS) Tops Q2 EPS by 22c

Leerink Partners Raises Price Target on Universal Health (UHS) Following 2Q EPS Beat

August 3, 2015 9:41 AM EDT

Leerink Partners reiterated an Outperform rating on Universal Health Services (NYSE: UHS), and raises the price target to $165.00 (from $155.00), following 2Q results. 2Q EBITDA of $433MM and Adj. EPS at $1.85 beat consensus at $404MM and $1.63 respectively. 2015 EPS guidance was raised by 9% to $6.75-7.15 which implies the EBITDA guidance raise by ~$100MM to $1,700MM at mean.

Analyst Ana Gupte commented, "UHS posted a strong 2Q with top & bottom-line beats. Solid beat on Same... More